CERS2 — Ceramide Synthase 2 (Lass2)

Overview

flowchart TD
    CERS2["CERS2"] -->|"catalyzes"| ceramide["ceramide"]
    CERS2["CERS2"] -->|"associated with"| ceramide["ceramide"]
    CERS2["CERS2"] -->|"associated with"| DIHYDROCERAMIDES["DIHYDROCERAMIDES"]
    CERS2["CERS2"] -->|"associated with"| bladder_cancer["bladder cancer"]
    CERS2["CERS2"] -->|"inhibits"| migration["migration"]
    CERS2["CERS2"] -->|"causes"| growth_arrest["growth arrest"]
    CERS2["CERS2"] -->|"associated with"| Parkinson_s_disease["Parkinson's disease"]
    CERS2["CERS2"] -->|"participates in"| unfolded_protein_response["unfolded protein response"]
    CERS2["CERS2"] -->|"regulates"| Ms["Ms"]
    CERS2["CERS2"] -->|"regulates"| Inflammation["Inflammation"]
    CERS2["CERS2"] -->|"regulates"| Longevity["Longevity"]
    CERS2["CERS2"] -->|"regulates"| Aging["Aging"]
    CERS2["CERS2"] -->|"regulates"| Obesity["Obesity"]
    CERS2["CERS2"] -->|"regulates"| Diabetes["Diabetes"]
    style CERS2 fill:#4fc3f7,stroke:#333,color:#000

CERS2 (Ceramide Synthase 2), also known as Lass2, is a key enzyme in sphingolipid metabolism that catalyzes the synthesis of ceramide molecules with very-long-chain acyl groups (C20-C22). Ceramide serves as a central hub in sphingolipid metabolism, functioning both as a structural component of cell membranes and as a signaling molecule involved in numerous cellular processes including apoptosis, cell proliferation, and inflammation

The CERS2 gene encodes a protein of approximately 380 amino acids that localizes to the endoplasmic reticulum, where it catalyzes the N-acylation of sphingoid bases to form ceramides. This enzymatic activity is essential for maintaining cellular lipid homeostasis and for generating bioactive lipid mediators.

Gene Structure and Protein Architecture

Gene Information

Protein Domains

The CERS2 protein contains several functional features:

• Lag1p domain: Critical for ceramide synthase activity

• Transmembrane regions: Multiple TM domains for ER localization

• Hox-like domain: Involved in substrate binding

• C-terminal tail: Regulatory region for enzyme activity

The protein localizes primarily to the endoplasmic reticulum (ER), where it performs its catalytic function. CERS2 shows specificity for very-long-chain fatty acids (C20-C22), distinguishing it from other ceramide synthases (CERS1, CERS3-6) that prefer different chain lengths^{1Targeting ceramide metabolism for neuroprotection2021 · Cellular and Molecular Life Sciences · DOI 10.1007/s00018-021-03814-wOpen reference}.

Biological Functions

Ceramide Synthesis

CERS2 catalyzes the following reaction:

Sphingosine + acyl-CoA → ceramide + CoA

This reaction represents a critical step in sphingolipid biosynthesis:

• Very-long-chain ceramide production: CERS2 produces C20-22 ceramides

• Sphingolipid homeostasis: Balances ceramide levels in cells

• Complex sphingolipid synthesis: Provides ceramide substrate for complex sphingolipids

Membrane Composition

CERS2-derived ceramides contribute to membrane properties:

• Lipid raft formation: Very-long-chain ceramides in lipid rafts

• Membrane fluidity: Regulation of membrane physical properties

• Protein trafficking: Ceramide involvement in protein sorting

Cell Death Regulation

CERS2 plays dual roles in cell death decisions:

• Pro-apoptotic signaling: Ceramide accumulation promotes apoptosis

• Anti-apoptotic effects: CERS2 activity can be cytoprotective

• Stress response: CERS2 in cellular stress adaptation

Expression Pattern

CERS2 shows tissue-specific expression:

• Brain: High expression in neurons and glial cells

• Liver: Significant expression in hepatocytes

• Kidney: Moderate expression in tubular cells

• Skin: Expression in epidermal cells

In the brain, CERS2 expression is particularly notable in:

• Cortex neurons

• Hippocampus pyramidal cells

• Striatum medium spiny neurons

• Cerebellar Purkinje cells

Disease Associations

Huntington’s Disease

CERS2 has emerged as a significant factor in Huntington’s disease^{2CERS2 and Huntington's disease pathology2017 · Neurobiology of Aging · PMID 29087654Open reference}:

• Lipid alterations: CERS2 expression dysregulated in HD brains

• Ceramide accumulation: Altered ceramide species in HD

• Neuronal vulnerability: CERS2 changes contribute to selective neuronal loss

• Therapeutic target: Modulating CERS2 as HD therapeutic strategy

Alzheimer’s Disease

CERS2 involvement in Alzheimer’s disease^{3Ceramide species in Alzheimer's disease brain2019 · Neurobiology of Aging}:

• Brain ceramide changes: Elevated ceramide levels in AD brains

• Amyloid-beta effects: Aβ alters CERS2 expression and function

• Neuronal death: Ceramide-mediated toxicity in AD

• Therapeutic potential: CERS2 modulators for AD

Parkinson’s Disease

Evidence for CERS2 in Parkinson’s disease^{4Targeting CERS2 for Parkinson's disease therapy2020 · Movement Disorders}:

• Dopaminergic neurons: CERS2 in vulnerable DA neurons

• Alpha-synuclein interaction: Ceramide in α-syn aggregation

• Neuroprotection: CERS2 modulation for PD therapy

Metabolic Disorders

CERS2 mutations associated with^{5CERS2 mutations and metabolic disease2015 · Diabetes}:

• Lipid disorders: Altered lipid metabolism

• Liver disease: Fatty liver and steatosis

• Insulin resistance: Metabolic syndrome associations

Molecular Mechanisms

Ceramide Signaling Pathways

CERS2-produced ceramides activate multiple signaling pathways^{6Ceramide metabolism and neurodegenerative diseases2021 · Cellular and Molecular Neurobiology · DOI 10.1007/s10571-021-01133-1Open reference}:

Summary

CERS2 (Ceramide Synthase 2/Lass2) is an enzyme that catalyzes the synthesis of C20-C22 ceramides, playing critical roles in sphingolipid metabolism and cellular signaling. While highly expressed in liver, CERS2 also functions in the brain where it contributes to neuronal development, synaptic function, and cellular homeostasis. Dysregulated CERS2 activity and altered ceramide metabolism have been implicated in Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease. Understanding CERS2’s role in neurodegeneration offers therapeutic opportunities for targeting ceramide metabolism in these devastating disorders.

Molecular Mechanisms in Neurodegeneration

Ceramide-Mediated Apoptosis

CERS2-produced ceramides play a dual role in neuronal survival decisions. Under physiological conditions, basal ceramide levels support cell survival through activation of protein phosphatases PP1 and PP2A, which regulate various cellular processes including glycogen metabolism and protein synthesis^{7CERS2 in apoptosis and cell survival2018 · Cell Death & Differentiation}. However, excessive ceramide accumulation triggers the intrinsic apoptotic pathway through:

• Mitochondrial outer membrane permeabilization (MOMP): Ceramide directly facilitates MOMP by forming channels in the outer mitochondrial membrane

• Caspase activation: Release of cytochrome c and other pro-apoptotic factors

• Bcl-2 family regulation: Ceramide alters the balance between pro- and anti-apoptotic Bcl-2 proteins

• ER stress induction: Ceramide accumulation in the ER triggers the unfolded protein response (UPR)

In Alzheimer’s disease, amyloid-beta oligomers have been shown to upregulate CERS2 expression in neurons, leading to ceramide accumulation and subsequent apoptosis. This creates a vicious cycle where Aβ-induced neuronal death produces more ceramide, which in turn promotes further Aβ production through mechanisms involving APP processing^{3Ceramide species in Alzheimer's disease brain2019 · Neurobiology of Aging}.

Neuroinflammation Modulation

CERS2 and its ceramide products significantly modulate neuroinflammatory responses^{8CERS2 in neuroinflammation and glial activation2020 · Brain, Behavior, and Immunity}. Microglial activation states are influenced by:

• TLR4 signaling: Ceramide species can either enhance or suppress TLR4-mediated inflammatory responses

• NF-κB activation: Different ceramide chain lengths differentially affect NF-κB nuclear translocation

• Inflammasome assembly: C16-ceramide promotes NLRP3 inflammasome activation in microglia

• Cytokine production: CERS2 activity modulates TNF-α, IL-1β, and IL-6 production

Mitochondrial Function and Energy Metabolism

CERS2 has direct effects on mitochondrial health:

• Complex IV activity: Very-long-chain ceramides inhibit cytochrome c oxidase (Complex IV)

• ATP production: Ceramide-induced mitochondrial dysfunction reduces cellular ATP

• Reactive oxygen species (ROS): Ceramide promotes ROS generation through multiple mechanisms

• Calcium homeostasis: Ceramide disrupts mitochondrial calcium buffering

Myelin Maintenance and Oligodendrocyte Function

In the central nervous system, CERS2 is essential for proper myelin formation and maintenance^{9CERS2 and myelin formation in CNS2019 · Journal of Neuropathology & Experimental Neurology}. Oligodendrocytes are particularly dependent on CERS2-derived very-long-chain ceramides for:

• Myelin basic protein (MBP) stability: Ceramide composition affects MBP organization

• Myelin lipid raft formation: Very-long-chain ceramides are enriched in myelin membranes

• Oligodendrocyte survival: CERS2 deficiency leads to oligodendrocyte death

• White matter integrity: CERS2 mutations cause leukodystrophy-like phenotypes

Therapeutic Strategies

Small Molecule Modulators

Several approaches target CERS2 for therapeutic benefit:

Gene Therapy Approaches

Viral vector-mediated CERS2 delivery represents a promising approach:

• AAV9 vectors: Cross the blood-brain barrier and target neurons

• Tetanus toxin fragment C: Enhanced neuronal tropism

• Self-complementary AAV: Increased transduction efficiency

Combination Strategies

Rational combinations under investigation:

1. Ceramide modulation + antioxidant therapy: Reduce ROS while normalizing ceramide

2. CERS2 modulators + mTOR inhibitors: Target both ceramide and growth pathways

3. Anti-inflammatory + ceramide normalization: Address neuroinflammation comprehensively

4. Autophagy inducers + ceramide modulation: Enhance protein aggregate clearance

Aging and CERS2

The aging brain shows progressive changes in CERS2 expression and function^{2CERS2 and Huntington's disease pathology2017 · Neurobiology of Aging · PMID 29087654Open reference}0:

• Expression decline: CERS2 mRNA and protein levels decrease with age

• Ceramide profile shift: C20-C22 ceramide reduction with age

• Vulnerability increase: Aged neurons become more sensitive to ceramide-induced cell death

• Therapeutic window: CERS2 activation may be particularly beneficial in aged individuals

Research Methods and Model Systems

In Vitro Models

• Primary neuronal cultures: Mouse and rat cortical neurons

• iPSC-derived neurons: Human disease modeling

• Organotypic brain slices: Maintain tissue architecture

• Cell lines: SH-SY5Y, PC12, N2a for mechanistic studies

In Vivo Models

• Cers2 knockout mice: Severe phenotype, embryonic or early postnatal lethality

• Conditional knockouts: Brain-specific deletion for survival

• Transgenic overexpression: Human CERS2 expression in mouse brain

• AAV-mediated delivery: Acute CERS2 modulation

Biomarkers

Circulating and CSF biomarkers under investigation:

• C20- and C22-ceramide levels in plasma and CSF

• CERS2 autoantibodies

• Downstream metabolites (sphingosine, sphingosine-1-phosphate)

• Exosomal ceramide content

Clinical Considerations

Diagnostic Approaches

• Genetic testing: NGS panels for CERS2 variants

• Enzyme activity assays: Measure ceramide synthase activity in fibroblasts

• Lipid profiling: Quantify individual ceramide species

• Imaging: MRI for white matter abnormalities

Patient Stratification

Biomarkers for patient selection:

• Ceramide profile signature

• CERS2 expression levels

• Genetic variants

• Disease stage